Imiglucerase Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 200 U/vial, 400 U/vial
Reference Brands: Cerezyme (USA/EU)
Category:
Immune Disorder
Imiglucerase is a recombinant DNA–derived form of the human enzyme β-glucocerebrosidase, used in enzyme replacement therapy for patients with Type 1 Gaucher disease. It helps break down fatty substances (glucocerebrosides) that accumulate in organs and tissues, thereby reducing symptoms such as anemia, enlarged liver/spleen, and bone pain.
Imiglucerase is available in Injection
and strengths such as 200 U/vial, 400 U/vial.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Imiglucerase is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Imiglucerase can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing